Package-Ref? Colorectal cancer SDC2/Septin 9 for Methylation control
CBPE0402
詢 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| Introduction | ||||||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Colorectal cancer, We use simulated clinical cell lines to prepare them. If you are testing SDC2/Septin 9, you can choose this product. |
|||||
| Technical Data | ||||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
|
質(zhì)控品 |
CBPE0402-1 | 結(jié)直腸癌-SDC2,Septin9陽性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-2 | 結(jié)直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-3 | 結(jié)直腸癌-SDC2陰性甲基化，Septin9陽性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||
| Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | 95.21% | ||||
| CBPE0402-4 | 結(jié)直腸癌-Septin9陰性甲基化，SDC2陽性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | 69.82% | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽SDC2-參考品 |
單陽SDC2 區(qū)段-強(qiáng)陽性參考品-1 |
CBPE0402-5 | SDC2強(qiáng)陽性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 65.00% | Chr8:97506434-97506502(hg19) | 69.82% |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
|
單陽SDC2 區(qū)段-強(qiáng)陽性參考品-2 |
CBPE0402-6 | SDC2強(qiáng)陽性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 10.00% | Chr8:97506434-97506502(hg19) | 9.91% | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽SDC2 區(qū)段-弱陽性參考品 |
CBPE0402-7 | SDC2弱陽性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽SDC2 區(qū)段-檢測限參考品 |
CBPE0402-8 | SDC2檢測限甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 1.00% | Chr8:97506434-97506502(hg19) | 1.20% | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽SDC2 區(qū)段-陰性參考品 |
CBPE0402-9 | 結(jié)直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽SDC2 區(qū)段-精密度參考品 |
CBPE0402-10 | SDC2弱陽性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-11 | 結(jié)直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽Septin9-參考品 |
單陽Septin9 區(qū)段-強(qiáng)陽性參考品-1 |
CBPE0402-12 | Septin9強(qiáng)陽性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 90.00% | Chr17:75369001-75369079(hg19) | 95.21% |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||||
|
單陽Septin9 區(qū)段-強(qiáng)陽性參考品-2 |
CBPE0402-13 | Septin9強(qiáng)陽性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 10.00% | Chr17:75369001-75369079(hg19) | 10.90% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽Septin9 區(qū)段-弱陽性參考品 |
CBPE0402-14 | Septin9弱陽性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽Septin9 區(qū)段-檢測限參考品 |
CBPE0402-15 | Septin9檢測限甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 1.00% | Chr17:75369001-75369079(hg19) | 1.36% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽Septin9 區(qū)段-陰性參考品 |
CBPE0402-16 | 結(jié)直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽Septin9 區(qū)段-精密度參考品 |
CBPE0402-17 | Septin9弱陽性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
| CBPE0402-18 | 結(jié)直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| 備注 | 1. 質(zhì)控品也叫準(zhǔn)確度標(biāo)準(zhǔn)品，用于定性判斷； 2. 參考品用于定性和定量的判斷，其中強(qiáng)陽、弱陽、檢測限、精密度、特異性的判定需要視具體項(xiàng)目而定，本產(chǎn)品的判定僅為內(nèi)部標(biāo)準(zhǔn)； 3. 質(zhì)控品用于性能評(píng)價(jià)，出廠檢，試劑盒日常檢測判定，參考品用于性能評(píng)價(jià)，出廠檢； 4.上述產(chǎn)品只展示了部分結(jié)果，甲基化程度可以定制。 |
|||||
| Product Information | ||||||
| Intended Use | Research Use Only | |||||
| Concentration | Download for COA | |||||
| Purity | Download for COA | |||||
| DNA electrophoresis | Download for COA | |||||
| Format | Genomic DNA | |||||
| Unit Size | 1ug | |||||
| Storage | 2-8°C | |||||
| Expiry | 36 months from the date of manufacture | |||||
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |||||
